• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

非致病性大肠杆菌对产志贺毒素大肠杆菌生长的抑制作用

Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli.

作者信息

Reissbrodt Rolf, Hammes Walter P, dal Bello Fabio, Prager Rita, Fruth Angelika, Hantke Klaus, Rakin Alexander, Starcic-Erjavec Marjanca, Williams Peter H

机构信息

Robert Koch Institut, Wernigerode Branch, Wernigerode, Germany.

出版信息

FEMS Microbiol Lett. 2009 Jan;290(1):62-9. doi: 10.1111/j.1574-6968.2008.01405.x. Epub 2008 Nov 10.

DOI:10.1111/j.1574-6968.2008.01405.x
PMID:19016876
Abstract

During routine quality control testing of diagnostic methods for Shiga toxin-producing Escherichia coli (STEC) using stool samples spiked with STEC, it was observed that the Shiga toxin could not be detected in 32 out of 82 samples tested. Strains of E. coli isolated from such stool samples were shown to be responsible for this inhibition. One particular isolate, named E. coli 1307, was intensively studied because of its highly effective inhibitory effect; this strain significantly reduced growth and Shiga toxin levels in coculture of several STEC strains regardless of serovar or Shiga toxin type. The probiotic E. coli Nissle 1917 inhibited growth and reduced Shiga toxin levels in STEC cultures to an extent similar to E. coli 1307, but commensal E. coli strains and several other known probiotic bacteria (enterococci, Bacillus sp., Lactobacillus acidophilus) showed no, or only small, inhibitory effects. Escherichia coli 1307 lacks obvious fitness factors, such as aerobactin, yersiniabactin, microcins and a polysaccharide capsule, that are considered to promote the growth of pathogenic bacteria. We therefore propose strain E. coli 1307 as a candidate probiotic for use in the prevention and treatment of infections caused by STEC.

摘要

在使用添加了产志贺毒素大肠杆菌(STEC)的粪便样本对STEC诊断方法进行常规质量控制检测期间,观察到在82个检测样本中有32个样本未检测到志贺毒素。从这类粪便样本中分离出的大肠杆菌菌株被证明是造成这种抑制作用的原因。其中一个名为大肠杆菌1307的特定分离株因其高效的抑制作用而受到深入研究;无论血清型或志贺毒素类型如何,该菌株在几种STEC菌株的共培养中均能显著降低生长和志贺毒素水平。益生菌大肠杆菌Nissle 1917对STEC培养物生长的抑制作用以及对志贺毒素水平的降低程度与大肠杆菌1307相似,但共生大肠杆菌菌株和其他几种已知的益生菌(肠球菌、芽孢杆菌属、嗜酸乳杆菌)则没有抑制作用,或只有很小的抑制作用。大肠杆菌1307缺乏明显的适应性因子,如气杆菌素、耶尔森菌素、微菌素和多糖荚膜,而这些因子被认为可促进病原菌的生长。因此,我们提议将大肠杆菌1307菌株作为预防和治疗STEC感染的候选益生菌。

相似文献

1
Inhibition of growth of Shiga toxin-producing Escherichia coli by nonpathogenic Escherichia coli.非致病性大肠杆菌对产志贺毒素大肠杆菌生长的抑制作用
FEMS Microbiol Lett. 2009 Jan;290(1):62-9. doi: 10.1111/j.1574-6968.2008.01405.x. Epub 2008 Nov 10.
2
A multiple protocol to improve diagnosis and isolation of Shiga toxin-producing Escherichia coli from human stool specimens.一种用于改善从人类粪便标本中诊断和分离产志贺毒素大肠杆菌的多重方案。
Diagn Microbiol Infect Dis. 2008 Sep;62(1):7-10. doi: 10.1016/j.diagmicrobio.2008.05.001. Epub 2008 Jun 11.
3
The effect of probiotics and organic acids on Shiga-toxin 2 gene expression in enterohemorrhagic Escherichia coli O157:H7.益生菌和有机酸对肠出血性大肠杆菌O157:H7中志贺毒素2基因表达的影响。
J Microbiol Methods. 2008 May;73(2):125-32. doi: 10.1016/j.mimet.2008.01.014. Epub 2008 Feb 11.
4
Preliminary evaluation of a procedure for improved detection of Shiga toxin-producing Escherichia coli in fecal specimens.粪便标本中改进产志贺毒素大肠杆菌检测方法的初步评估
Diagn Microbiol Infect Dis. 2009 Sep;65(1):21-6. doi: 10.1016/j.diagmicrobio.2009.05.012.
5
Escherichia coli O157:H7 and other Shiga toxin-producing E. coli in white veal calves.白色小牛肉犊牛中的大肠杆菌O157:H7及其他产志贺毒素大肠杆菌
Vet Microbiol. 2008 Jan 1;126(1-3):200-9. doi: 10.1016/j.vetmic.2007.06.012. Epub 2007 Jun 22.
6
Shiga-toxigenic Escherichia coli O157 and non-Shiga-toxigenic E. coli O157 respond differently to culture and isolation from naturally contaminated bovine faeces.产志贺毒素大肠杆菌O157和非产志贺毒素大肠杆菌O157对从自然污染的牛粪中进行培养和分离的反应不同。
J Appl Microbiol. 2007 Dec;103(6):2457-64. doi: 10.1111/j.1365-2672.2007.03473.x.
7
Novel differential and confirmation plating media for Shiga toxin-producing Escherichia coli serotypes O26, O103, O111, O145 and sorbitol-positive and -negative O157.用于产志贺毒素大肠杆菌血清型O26、O103、O111、O145以及山梨醇阳性和阴性O157的新型鉴别和确证平板培养基。
FEMS Microbiol Lett. 2008 May;282(1):124-31. doi: 10.1111/j.1574-6968.2008.01121.x. Epub 2008 Mar 18.
8
Importance of culture confirmation of shiga toxin-producing Escherichia coli infection as illustrated by outbreaks of gastroenteritis--New York and North Carolina, 2005.2005年纽约和北卡罗来纳州肠胃炎暴发所表明的产志贺毒素大肠杆菌感染培养确诊的重要性
MMWR Morb Mortal Wkly Rep. 2006 Sep 29;55(38):1042-5.
9
Growth of Shiga-toxin producing Escherichia coli (STEC) and bovine feces background microflora in various enrichment protocols.产志贺毒素大肠杆菌(STEC)及牛粪背景微生物群在不同富集培养方案中的生长情况。
Vet Microbiol. 2007 Jul 20;123(1-3):274-81. doi: 10.1016/j.vetmic.2007.02.003. Epub 2007 Feb 9.
10
Characteristics of O157 versus non-O157 Shiga toxin-producing Escherichia coli infections in Minnesota, 2000-2006.2000 - 2006年明尼苏达州产志贺毒素大肠杆菌O157感染与非O157感染的特征
Clin Infect Dis. 2009 Aug 1;49(3):358-64. doi: 10.1086/600302.

引用本文的文献

1
Development of Sucrose-Utilizing Nissle 1917 for Efficient Heparosan Biosynthesis.用于高效合成乙酰肝素的蔗糖利用型Nissle 1917的开发。
Metabolites. 2025 Jun 18;15(6):410. doi: 10.3390/metabo15060410.
2
MIMIC: a Python package for simulating, inferring, and predicting microbial community interactions and dynamics.MIMIC:一个用于模拟、推断和预测微生物群落相互作用及动态的Python软件包。
Bioinformatics. 2025 May 6;41(5). doi: 10.1093/bioinformatics/btaf174.
3
Bacterial microcompartment utilization in the human commensal Nissle 1917.
人类共生菌1917株中细菌微区室的利用
J Bacteriol. 2024 Dec 19;206(12):e0026924. doi: 10.1128/jb.00269-24. Epub 2024 Dec 5.
4
From the Microbiome to the Electrome: Implications for the Microbiota-Gut-Brain Axis.从微生物组到电医学:对微生物群-肠-脑轴的影响。
Int J Mol Sci. 2024 Jun 5;25(11):6233. doi: 10.3390/ijms25116233.
5
Advances in Nissle 1917 as a customizable drug delivery system for disease treatment and diagnosis strategies.Nissle 1917作为用于疾病治疗和诊断策略的可定制药物递送系统的研究进展。
Mater Today Bio. 2023 Jan 6;18:100543. doi: 10.1016/j.mtbio.2023.100543. eCollection 2023 Feb.
6
Characterization of siderophores from Escherichia coli strains through genome mining tools: an antiSMASH study.通过基因组挖掘工具对大肠杆菌菌株中的铁载体进行表征:一项antiSMASH研究。
AMB Express. 2022 Jun 15;12(1):74. doi: 10.1186/s13568-022-01421-x.
7
Prenatal versus Postnatal Initial Colonization of Healthy Neonates' Colon Ecosystem by the Enterobacterium Escherichia coli.健康新生儿肠道生态系统中肠杆菌属大肠杆菌的产前与产后初始定植。
Microbiol Spectr. 2021 Dec 22;9(3):e0037921. doi: 10.1128/Spectrum.00379-21. Epub 2021 Nov 24.
8
Role of probiotics in prevention and treatment of enteric infections: a comprehensive review.益生菌在预防和治疗肠道感染中的作用:一项全面综述。
3 Biotech. 2021 May;11(5):242. doi: 10.1007/s13205-021-02796-7. Epub 2021 Apr 27.
9
Immuno-modulatory effect of probiotic E. coli Nissle 1917 in polarized human colonic cells against Campylobacter jejuni infection.益生菌大肠杆菌 Nissle 1917 对弯曲杆菌感染的极化人结肠细胞的免疫调节作用。
Gut Microbes. 2021 Jan-Dec;13(1):1-16. doi: 10.1080/19490976.2020.1857514.
10
Therapeutic Strategies to Protect the Central Nervous System against Shiga Toxin from Enterohemorrhagic .针对肠出血性大肠杆菌产生的志贺毒素保护中枢神经系统的治疗策略
Curr Neuropharmacol. 2021;19(1):24-44. doi: 10.2174/1570159X18666200220143001.